One of the downstream pathways is the phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, known to be one of the most commonly activated signaling pathways in cancer, leading to cell proliferation, survival and differentiation. Here, MTOR is linked to cancer.